- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
TNFSF15 antibody recognizes Vascular endothelial growth inhibitor, also known as VEGI and TL1A, a cytokine encoded by the TNFSF15 gene. TNFSF15 is a member of the tumor necrosis factor ligand superfamily and is primarily expressed by endothelial cells and select immune cell populations. VEGI functions as an anti-angiogenic and immune-regulatory factor, influencing vascular remodeling and inflammatory signaling pathways. TNFSF15 Antibody Microarray Validated is developed to detect endogenous Vascular endothelial growth inhibitor in research applications focused on angiogenesis and immune regulation.
VEGI binds to death receptor 3, also known as TNFRSF25, activating downstream signaling cascades that regulate apoptosis, cytokine production, and T cell responses. Through this interaction, TNFSF15 modulates endothelial cell proliferation and helps maintain vascular homeostasis. In addition to its anti-angiogenic effects, VEGI plays an important role in shaping adaptive immune responses, particularly in T helper cell activation and differentiation.
The TNFSF15 gene is located on chromosome 9q32 and encodes a type II transmembrane protein that can be cleaved to generate a soluble form. VEGI expression has been detected in vascular endothelium, intestinal tissue, and immune-associated compartments. Dysregulated TNFSF15 signaling has been linked to inflammatory bowel disease, autoimmune conditions, and tumor-associated vascular remodeling. In oncologic research, VEGI has been investigated for its capacity to inhibit tumor angiogenesis and suppress growth of certain malignancies by limiting vascular supply.
Microarray validation supports specificity profiling of this antibody against a broad panel of proteins, providing an additional level of confidence for target recognition. By targeting TNFSF15, this recombinant rabbit monoclonal antibody supports studies of VEGI-mediated signaling, endothelial biology, immune modulation, and angiogenic regulation.
Clone VEGI/2052R is a recombinant rabbit monoclonal antibody that recognizes Vascular endothelial growth inhibitor and is suitable for detecting TNFSF15 expression in diverse research models.
Titration of the recombinant TNFSF15 antibody may be required for optimal performance.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
A full length human recombinant protein was used as the immunogen for this recombinant TNFSF15 antibody.
Store the recombinant TNFSF15 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.